Obesity is a strong determinant of hypertensive target organ damage in young-to-middle-age patients

[1]  T. Kotchen.  Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. , 2010, American journal of hypertension.

[2]  M. Esler,et al.  Sympathetic Nervous System Activity Is Associated With Obesity-Induced Subclinical Organ Damage in Young Adults , 2010, Hypertension.

[3]  N. Scopinaro,et al.  Sub-clinical organ damage in hypertension and obesity. , 2010, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[4]  Guido Grassi,et al.  Assessment of Sympathetic Cardiovascular Drive in Human Hypertension: Achievements and Perspectives , 2009, Hypertension.

[5]  N. Timpson,et al.  Does Greater Adiposity Increase Blood Pressure and Hypertension Risk?: Mendelian Randomization Using the FTO/MC4R Genotype , 2009, Hypertension.

[6]  P. Palatini,et al.  Regular physical activity prevents development of left ventricular hypertrophy in hypertension. , 2008, European heart journal.

[7]  J. Cutler,et al.  Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults Between 1988–1994 and 1999–2004 , 2008, Hypertension.

[8]  P. Palatini,et al.  Effect of body weight loss on blood pressure after 6 years of follow-up in stage 1 hypertension. , 2006, American journal of hypertension.

[9]  C. Papamichael,et al.  Impact of Obesity in Intima Media Thickness of Carotid Arteries , 2006, Obesity.

[10]  P. Palatini,et al.  Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. , 2006, Kidney international.

[11]  K. Narkiewicz.  Diagnosis and management of hypertension in obesity , 2006, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[12]  Youfa Wang,et al.  The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. , 2004, Archives of internal medicine.

[13]  M. Pepe,et al.  Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. , 2004, American journal of epidemiology.

[14]  S. Daniels,et al.  The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. , 2004, Pediatrics.

[15]  P. Palatini,et al.  G-Protein &bgr;3-Subunit Gene 825T Allele and Hypertension: A Longitudinal Study in Young Grade I Hypertensives , 2003, Hypertension.

[16]  E. Mannarino,et al.  High-density lipoprotein cholesterol and left ventricular hypertrophy in essential hypertension , 2001, Journal of hypertension.

[17]  L. Cubeddu,et al.  Urinary albumin excretion in lean, overweight and obese glucose tolerant individuals: its relationship with dyslipidaemia, hyperinsulinaemia and blood pressure , 2001, Journal of Human Hypertension.

[18]  P. Okin,et al.  Prognostic implications of left ventricular hypertrophy. , 2001, American heart journal.

[19]  J. Chan,et al.  Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese. , 2001, Metabolism: clinical and experimental.

[20]  S. Nesbitt,et al.  Determinants of left ventricular structure and mass in young subjects with sympathetic over‐activity. The Tecumseh Offspring Study , 2000, Journal of hypertension.

[21]  P. Palatini,et al.  Clinical value of microalbuminuria in hypertension , 2000, Journal of hypertension.

[22]  M. Schroll,et al.  Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. , 2000, Hypertension.

[23]  S. Julius,et al.  Overweight and hypertension : a 2-way street? , 2000, Hypertension.

[24]  GiuseppeSchillaci,et al.  Continuous Relation Between Left Ventricular Mass and Cardiovascular Risk in Essential Hypertension , 2000 .

[25]  K. Jöckel,et al.  Effect of age on excess mortality in obesity. , 1999, JAMA.

[26]  L. Bouter,et al.  Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[27]  Douglas G Altman,et al.  Odds ratios should be avoided when events are common , 1998, BMJ.

[28]  S. Daniels,et al.  Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. , 1998, Circulation.

[29]  P. Palatini,et al.  Relation between physical training and ambulatory blood pressure in stage I hypertensive subjects. Results of the HARVEST Trial. Hypertension and Ambulatory Recording Venetia Study. , 1994, Circulation.

[30]  A. Tamir,et al.  [Microalbuminuria and ischemic heart disease in noninsulin-dependent diabetes]. , 1994, Harefuah.

[31]  S. Daniels,et al.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. , 1992, Journal of the American College of Cardiology.

[32]  Manfred Bohm,et al.  Achievements And Perspectives Of Fiber Gyros , 1986, Other Conferences.

[33]  J. Laragh,et al.  Standardization of M-mode echocardiographic left ventricular anatomic measurements. , 1984, Journal of the American College of Cardiology.

[34]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[35]  P. Touboul.  Intima-media thickness of carotid arteries. , 2015, Frontiers of neurology and neuroscience.

[36]  W. Elliott.  Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults Between 1988–1994 and 1999–2004 , 2009 .

[37]  GraspingEric Paulospaulos,et al.  Trends in the , 2003 .

[38]  M. Thun,et al.  The effect of age on the association between body-mass index and mortality. , 1998, The New England journal of medicine.

[39]  P. Peduzzi,et al.  Comparison of the logistic and Cox regression models when outcome is determined in all patients after a fixed period of time. , 1987, Journal of chronic diseases.